SALT LAKE CITY, Sept. 28, 2012 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: [ DYNT ]) today announced results for its fiscal fourth quarter and year ended June 30, 2012.

Net income for the quarter ended June 30, 2012, increased to $115,954 ($.01 per common share), compared to net income of $68,776 ($.01 per common share) for the same quarter in the prior fiscal year. Net loss for the year ended June 30, 2012, was $23,535 ($.00 per common share), compared to net income of $270,888 ($.02 per common share) for the year ended June 30, 2011.

Sales for the fiscal fourth quarter ended June 30, 2012, declined 5.5 percent to $7,738,363, compared to $8,190,383 for the quarter ended June 30, 2011. Sales for the year ended June 30, 2012, were $31,664,181, compared to $32,692,859 for the year ended June 30, 2011 representing a 3.1 percent decline.

"Fourth quarter profits improved despite a weakness in top-line sales," said Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "We were successful in reducing both SG&A and R&D costs to compensate for the sluggish markets we have been facing over the past three years. These operating improvements, combined with an income tax benefit related to R&D tax credits recorded during the fourth fiscal quarter, resulted in a net profit of $115,954 for the fourth quarter which was a significant turnaround from the net loss of $117,563 in the third quarter. Given ongoing economic weakness that was more pronounced in the last six months of the fiscal year, we have implemented strategies to help move the company forward despite such general economic concerns."

To combat the challenging economic trends, the company's strategic plan calls for the introduction of a record number of new products to spur interest in our most profitable segment of capital equipment and to position the company for growth.

"With last week's introduction of the SolarisPlus line of products, we are beginning to see renewed excitement among the sales force and increased interest in capital equipment purchases by customers," Cullimore continued. "This new line of electrotherapy, ultrasound and light therapy units represents our premier line of combination therapy devices and is attracting solid attention among practitioners. Not only are these units the most powerful we have ever developed, but they offer the greatest flexibility for practitioners to treat their patients."

"Since introducing the SolarisPlus devices, demand for capital equipment appears to be picking up," stated Larry K. Beardall, executive vice president of sales and marketing. "We fully expect that the record number of new products being introduced this year will help boost sales even in the face of a flagging economy."

The company plans to introduce additional new products over the coming months and is nearing the completion of its 2013 - 2014 product catalog, which will feature a number of new distributed medical supplies for practitioners.

"We believe that our strategy of introducing new products, combined with our cost reduction program and continued effort with large national accounts, will enable our company to improve its financial results and increase market share," concluded Cullimore.

Dynatronics has scheduled a conference call for investors on Friday, September 28, 2012, at 4:30 p.m. ET. Those wishing to participate should call (800) 616-7436.

The following is a summary of the financial results as of June 30, 2012 and 2011, and for the three-month period and year then ended:

Summary Selected Financial Data
Statement of Operations Highlights

	Three Months Ended		Year Ended
	June 30,		June 30,
	2012	2011	2012	2011

Net sales	$ 7,738,363	$ 8,190,383	$ 31,664,181	$ 32,692,859
Cost of sales	4,855,143	5,051,225	19,720,948	20,208,035
Gross profit	2,883,220	3,139,158	11,943,233	12,484,824
SG&A expenses	2,457,325	2,656,615	10,506,460	10,431,463
R&D expenses	279,286	338,138	1,410,406	1,383,712
Other expenses, net	57,660	63,156	216,608	250,785
Net income (loss) before income
tax (benefit) provision	88,949	81,249	(190,241)	418,864

Income tax benefit (provision)	27,005	(12,473)	166,706	(147,976)

Net income (loss)	$ 115,954	$ 68,776	$ (23,535)	$ 270,888
Diluted net income (loss)
per common share	$ 0.01	$ 0.01	$ (0.00)	$ 0.02

Balance Sheet Highlights

	June 30,	June 30,
	2012	2011

Cash	$ 278,263	$ 384,904
Accounts receivable	3,667,086	3,672,128
Inventories	6,098,597	5,647,815
Total current assets	10,654,158	10,432,811
Total assets	15,270,930	14,819,181

Accounts payable	2,413,201	2,127,163
Accrued expenses	386,229	379,336
Line of credit	3,497,597	2,583,937
Total current liabilities	7,088,300	5,880,080
Total liabilities	9,004,615	8,204,022
Total liabilities and equity	15,270,930	14,819,181

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at [ www.dynatronics.com ].

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding expectations for future new product line introductions and growth. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost-effective rates, and the risk factors listed from time to time in the company's SEC reports.

SOURCE Dynatronics Corporation

[ Back to top ]

RELATED LINKS
[ http://www.dynatronics.com ]

Contributing Sources

Market Wire

N@N

Dynatronics Announces Fourth Quarter and Year-End Results

Dynatronics Announces Fourth Quarter and Year-End Results